Article
Valproate teratogenicity and epilepsy syndrome
13 Jun 2008
Abstract excerpt
Maternal valproate (VPA) use is associated with a significant risk for congenital malformations in the exposed fetus. Since VPA is commonly used in epilepsy syndromes with a presumed genetic cause (idiopathic epilepsies), it is possible that maternal genetic background contributes to this outcome. We reviewed responses to telephone questionnaires and medical records, when available, of enrollees in the North...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
